JPWO2020201078A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2020201078A5
JPWO2020201078A5 JP2021556866A JP2021556866A JPWO2020201078A5 JP WO2020201078 A5 JPWO2020201078 A5 JP WO2020201078A5 JP 2021556866 A JP2021556866 A JP 2021556866A JP 2021556866 A JP2021556866 A JP 2021556866A JP WO2020201078 A5 JPWO2020201078 A5 JP WO2020201078A5
Authority
JP
Japan
Prior art keywords
fragments
level
biomarker
prescribing
reference value
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021556866A
Other languages
English (en)
Japanese (ja)
Other versions
JP7575400B2 (ja
JP2022526507A5 (https=
JP2022526507A (ja
Publication date
Priority claimed from EP19166382.2A external-priority patent/EP3715851A1/en
Application filed filed Critical
Priority claimed from PCT/EP2020/058700 external-priority patent/WO2020201078A1/en
Publication of JP2022526507A publication Critical patent/JP2022526507A/ja
Publication of JPWO2020201078A5 publication Critical patent/JPWO2020201078A5/ja
Publication of JP2022526507A5 publication Critical patent/JP2022526507A5/ja
Priority to JP2024181851A priority Critical patent/JP2025015545A/ja
Application granted granted Critical
Publication of JP7575400B2 publication Critical patent/JP7575400B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021556866A 2019-03-29 2020-03-27 バイオマーカーに基づく遠隔患者管理の処方 Active JP7575400B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024181851A JP2025015545A (ja) 2019-03-29 2024-10-17 バイオマーカーに基づく遠隔患者管理の処方

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
EP19166425.9 2019-03-29
EP19166382.2A EP3715851A1 (en) 2019-03-29 2019-03-29 Prescription of remote patient management based on biomarkers
EP19166382.2 2019-03-29
EP19166425 2019-03-29
EP19175720.2 2019-05-21
EP19175720 2019-05-21
PCT/EP2020/058700 WO2020201078A1 (en) 2019-03-29 2020-03-27 Prescription of remote patient management based on biomarkers

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024181851A Division JP2025015545A (ja) 2019-03-29 2024-10-17 バイオマーカーに基づく遠隔患者管理の処方

Publications (4)

Publication Number Publication Date
JP2022526507A JP2022526507A (ja) 2022-05-25
JPWO2020201078A5 true JPWO2020201078A5 (https=) 2023-04-05
JP2022526507A5 JP2022526507A5 (https=) 2023-04-05
JP7575400B2 JP7575400B2 (ja) 2024-10-29

Family

ID=69941398

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021556866A Active JP7575400B2 (ja) 2019-03-29 2020-03-27 バイオマーカーに基づく遠隔患者管理の処方
JP2024181851A Pending JP2025015545A (ja) 2019-03-29 2024-10-17 バイオマーカーに基づく遠隔患者管理の処方

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024181851A Pending JP2025015545A (ja) 2019-03-29 2024-10-17 バイオマーカーに基づく遠隔患者管理の処方

Country Status (8)

Country Link
US (2) US12442825B2 (https=)
EP (1) EP3948301A1 (https=)
JP (2) JP7575400B2 (https=)
CN (1) CN113348368A (https=)
AU (1) AU2020253042B2 (https=)
BR (1) BR112021019479A2 (https=)
CA (3) CA3281050A1 (https=)
WO (1) WO2020201078A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11783944B2 (en) * 2019-09-09 2023-10-10 Neal F. Krouse System for live monitoring of vitals for patients and physicians
WO2022101937A1 (en) * 2020-11-12 2022-05-19 Shah Komal An integrated health data capture and analysis based device for evaluation, diagnosis and prognosis of heart failure
WO2022164724A1 (en) * 2021-01-27 2022-08-04 Verantos, Inc. High validity real-world evidence study with deep phenotyping
WO2022245405A1 (en) 2021-05-17 2022-11-24 Verantos, Inc. System and method for term disambiguation
US20240120105A1 (en) * 2022-10-09 2024-04-11 Morteza Naghavi Predicting adverse health risk based on ct scan images and ai-enabled cardiovascular structure volumetry
WO2025097159A1 (en) * 2023-11-05 2025-05-08 3Ive Labs, Llc Urinary oxygen and uses thereof in adaptive therapies for kidney function

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3943918A (en) 1971-12-02 1976-03-16 Tel-Pac, Inc. Disposable physiological telemetric device
US4121573A (en) 1973-10-04 1978-10-24 Goebel Fixture Co. Wireless cardiac monitoring system and electrode-transmitter therefor
FR2570703B1 (fr) 1984-09-26 1988-07-08 Commissariat Energie Atomique Complexes macropolycycliques de terres rares et application a titre de marqueurs fluorescents
US4827943A (en) 1986-09-23 1989-05-09 Advanced Medical Technologies, Inc. Portable, multi-channel, physiological data monitoring system
US4784162A (en) 1986-09-23 1988-11-15 Advanced Medical Technologies Portable, multi-channel, physiological data monitoring system
US4882733A (en) 1987-03-13 1989-11-21 Ford Aerospace Corporation Method and apparatus for combining encoding and modulation
US5511553A (en) 1989-02-15 1996-04-30 Segalowitz; Jacob Device-system and method for monitoring multiple physiological parameters (MMPP) continuously and simultaneously
US5307818A (en) 1989-02-15 1994-05-03 Jacob Segalowitz Wireless electrocardiographic and monitoring system and wireless electrode assemblies for same
US4981141A (en) 1989-02-15 1991-01-01 Jacob Segalowitz Wireless electrocardiographic monitoring system
US5168874A (en) 1989-02-15 1992-12-08 Jacob Segalowitz Wireless electrode structure for use in patient monitoring system
FR2664699B1 (fr) 1990-07-13 1995-08-18 Cis Bio Int Procede d'amplification du signal d'emission d'un compose luminescent.
US5353793A (en) 1991-11-25 1994-10-11 Oishi-Kogyo Company Sensor apparatus
US5214939A (en) 1991-11-25 1993-06-01 Carrier Corporation Variable area refrigerant expansion device having a flexible orifice
ES2155068T3 (es) 1992-04-03 2001-05-01 Micromedical Ind Ltd Sistema de supervision fisiologica.
US5522396A (en) 1992-05-12 1996-06-04 Cardiac Telecom Corporation Method and system for monitoring the heart of a patient
JP2774769B2 (ja) 1993-04-26 1998-07-09 賢治 寒川 アドレノメデュリン
US5544661A (en) 1994-01-13 1996-08-13 Charles L. Davis Real time ambulatory patient monitor
DE19847690A1 (de) 1998-10-15 2000-04-20 Brahms Diagnostica Gmbh Verfahren und Substanzen für die Diagnose und Therapie von Sepsis und sepsisähnlichen systemischen Infektionen
US6416471B1 (en) 1999-04-15 2002-07-09 Nexan Limited Portable remote patient telemonitoring system
DE10316583A1 (de) 2003-04-10 2004-10-28 B.R.A.H.M.S Aktiengesellschaft Bestimmung eines midregionalen Proadrenomedullin-Teilpeptids in biologischen Flüssigkeiten zu diagnostischen Zwecken, sowie Immunoassays für die Durchführung einer solchen Bestimmung
DE102006060112A1 (de) 2006-12-20 2008-06-26 Brahms Aktiengesellschaft Diagnose und Risikostratifizierung mittels dem neuen Marker CT-proADM
DE102007022367A1 (de) 2007-05-07 2008-11-20 B.R.A.H.M.S Ag Verfahren zur Bestimmung von aminoterminalen pro-ANP bei übergewichtigen Patienten
EP2107377A1 (en) * 2008-04-04 2009-10-07 BRAHMS Aktiengesellschaft Pro-endothelin-1 levels for the prediction of risk of tachyarrhytmic events
CN105044349B (zh) * 2010-08-26 2018-04-06 弗·哈夫曼-拉罗切有限公司 生物标志物在评估从动脉高血压向心力衰竭的早期转变中的用途
CN108931658A (zh) * 2018-04-16 2018-12-04 上海交通大学医学院附属瑞金医院 用于诊断心力衰竭合并症及预后评估的血清标记物

Similar Documents

Publication Publication Date Title
Mueller et al. B-type natriuretic peptide for acute dyspnea in patients with kidney disease: insights from a randomized comparison
Kurki et al. Preoperative prediction of postoperative morbidity in coronary artery bypass grafting
Gottdiener et al. Predictors of congestive heart failure in the elderly: the Cardiovascular Health Study
Fedullo et al. Acute cardiogenic pulmonary edema treated with mechanical ventilation: factors determining in-hospital mortality
Ong et al. Heart rate variability risk score for prediction of acute cardiac complications in ED patients with chest pain
Delmas et al. Design and preliminary results of FRENSHOCK 2016: a prospective nationwide multicentre registry on cardiogenic shock
Becher et al. Characteristics and long-term outcome of right ventricular involvement in Takotsubo cardiomyopathy
JP2025015545A5 (https=)
Castello-Simões et al. Circulatory and ventilatory power: characterization in patients with coronary artery disease
Gelsomino et al. Cost and cost-effectiveness of cardiac surgery in elderly patients
Edelson et al. Cardiopulmonary exercise testing in pediatric patients with hypertrophic cardiomyopathy
Rea et al. Pulmonary artery catheter usage and impact on mortality in patients with cardiogenic shock: results from a Canadian single-centre registry
Carrillo-Aleman et al. Effectiveness and safety of non-invasive ventilation in the management of cardiogenic shock
Tien et al. The CSP (cardiogenic shock prognosis) score: a tool for risk stratification of cardiogenic shock
Fumagalli et al. Incidence and determinants of atrial fibrillation in patients with wild-type transthyretin cardiac amyloidosis
Cirelli et al. Prognostic role of gait speed in worsening heart failure
JPWO2020201078A5 (https=)
Huang et al. Including hemoglobin levels and female sex provide the additional predictive value of the APPLE score for atrial fibrillation recurrence post-catheter ablation
Cherbi et al. Clinical profile, short and long‐term outcomes of non‐ischaemic cardiogenic shock: A FRENSHOCK sub‐analysis
Vazquez et al. Risk markers by sex for in-hospital mortality in patients with acute coronary syndrome: a machine learning approach
Levy et al. Prediction of mortality in patients with heart failure and systolic dysfunction
Kisters et al. NURSES’NIGHTSHIFT WORKLOAD: PSYCHOLOGIC, METABOLIC AND CARDIOVASCULAR DATA
Roselló et al. Impact of age on management and prognosis of resuscitated sudden cardiac death patients
RU2826095C1 (ru) Способ прогнозирования толерантности к физической нагрузке у пациентов со стабильной стенокардией в сочетании с железодефицитной анемией
Piotrowicz et al. Predictors of long-term prognosis based on clinical status and measurements obtained in heart failure patients after 9-week hybrid comprehensive telerehabilitation: A subanalysis of the TELEREH-HF randomized clinical trial